Centiva Capital »

Larimar Therapeutics shares owned by Centiva Capital

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Centiva Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $49k 16k 3.05

More positions owned by Centiva Capital

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust St Str Sp Regbnk (KRE)
Vaneck Etf Trust Semiconductr Etf (SMH)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Marvell Technology (MRVL)

View all positions for Centiva Capital

Top funds holding Larimar Therapeutics

Deerfield Management Company
Blue Owl Capital Holdings
BlackRock
Defilade Capital Management
Driehaus Capital Management
Vanguard Capital Management
Rtw Investments
AQR Capital Management
Marshall Wace
DAFNA Capital Management
Goldman Sachs Group
Citadel Advisors
Geode Capital Management
Qube Research & Technologies
Vanguard Portfolio Management

View all funds holding Larimar Therapeutics